Skip Navigation


ToxSci Advance Access originally published online on March 20, 2008
Toxicological Sciences 2008 104(1):144-154; doi:10.1093/toxsci/kfn059
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
104/1/144    most recent
kfn059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Peden-Adams, M. M.
Right arrow Articles by Keil, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peden-Adams, M. M.
Right arrow Articles by Keil, D. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Suppression of Humoral Immunity in Mice following Exposure to Perfluorooctane Sulfonate

Margie M. Peden-Adams*,{dagger},{ddagger},1, Jennifer M. Keller§, Jackie G. EuDaly{dagger},{ddagger}, Jennifer Berger, Gary S. Gilkeson{dagger},|| and Deborah E. Keil

* Department of Pediatrics {dagger} Department of Medicine/Rheumatology & Immunology {ddagger} Marine Biomedicine and Environmental Science Center, Medical University of South Carolina, Charleston, South Carolina, 29412 § National Institute of Standards and Technology, Hollings Marine Laboratory, Charleston, South Carolina, 29412 Clinical Laboratory Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, 89154 || Medical Research Service, Ralph Johnson VAMC, Charleston, South Carolina, 29403

1 To whom correspondence should be addressed at MUSC, 221 Ft. Johnson Rd, Charleston, SC 29412. Fax: (843) 762-8700. E-mail: pedenada{at}musc.edu.

Received January 25, 2008; accepted March 6, 2008


   Abstract

Adult male and female B6C3F1 mice were exposed to perfluorooctane sulfonate (PFOS) daily via gavage for 28 days (0, 0.005, 0.05, 0.1, 0.5, 1, or 5 mg/kg total administered dose [TAD]). Following exposure, various immune parameters were assessed and serum PFOS concentrations were determined. Lymphocyte proliferation was not altered in either gender. Natural killer cell activity was increased compared with control at 0.5, 1, and 5 mg/kg TAD in male mice but was not altered in female mice. At these treatment levels, splenic T-cell immunophenotypes were minimally altered in females, but all T-cell subpopulations were significantly modulated in males beginning at 0.1 mg/kg TAD. The sheep red blood cell (SRBC) plaque-forming cell (PFC) response was suppressed in male mice beginning at 0.05 mg/kg TAD and in females at 0.5 mg/kg TAD. Serum trinitrophenyl (TNP)–specific IgM titers were also decreased by PFOS after TNP–LPS (TNP conjugated to lipopolysacharide) challenge suggesting that the humoral immune effects may be attributed to the B-cell rather than T-cell because both T-dependent (SRBC) and T-independent (TI) (TNP–LPS) antigens result in suppressed IgM production. Based on the PFC response, the low observed effect level (LOEL) for males was 0.05 mg/kg TAD (ED50 = 0.021 mg/kg TAD) and for females was 0.5 mg/kg TAD (ED50 = 0.59 mg/kg TAD). Measured PFOS serum concentrations at these dose levels were 91.5 ± 22.2 ng/g and 666 ± 108 ng/g (mean ± SD), respectively. The male LOEL serum level was approximately 14-fold lower than reported mean blood levels from occupationally exposed humans and fell in the upper range of concentrations reported for the general population. Overall, this study provides a profile of PFOS immunotoxicity showing effects at levels reported in humans and identifies the B-cells as a potential target.

Key Words: PFOS; immunotoxicity; immune; humoral immunity; PFC assay; TNP–LPS; serum levels.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
J. C. DeWitt, C. B. Copeland, and R. W. Luebke
Suppression of Humoral Immunity by Perfluorooctanoic Acid is Independent of Elevated Serum Corticosterone Concentration in Mice
Toxicol. Sci., May 1, 2009; 109(1): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. E. Keil, W. D. McGuinn, A. C. Dudley, J. G. EuDaly, G. S. Gilkeson, and M. M. Peden-Adams
N,N,-Diethyl-m-Toluamide (DEET) Suppresses Humoral Immunological Function in B6C3F1 Mice
Toxicol. Sci., March 1, 2009; 108(1): 110 - 123.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.